106 related articles for article (PubMed ID: 4015715)
1. Metabolism of tamoxifen and its uterotrophic activity.
Lyman SD; Jordan VC
Biochem Pharmacol; 1985 Aug; 34(15):2787-94. PubMed ID: 4015715
[TBL] [Abstract][Full Text] [Related]
2. Hydroxylated metabolites of tamoxifen are formed in vivo and bound to estrogen receptor in target tissues.
Borgna JL; Rochefort H
J Biol Chem; 1981 Jan; 256(2):859-68. PubMed ID: 7451477
[TBL] [Abstract][Full Text] [Related]
3. Species-specific pharmacology of antiestrogens: role of metabolism.
Jordan VC; Robinson SP
Fed Proc; 1987 Apr; 46(5):1870-4. PubMed ID: 3556610
[TBL] [Abstract][Full Text] [Related]
4. Possible mechanisms for the agonist actions of tamoxifen and the antagonist actions of MER-25 (ethamoxytriphetol) in the mouse uterus.
Lyman SD; Jordan VC
Biochem Pharmacol; 1985 Aug; 34(15):2795-806. PubMed ID: 4015716
[TBL] [Abstract][Full Text] [Related]
5. Induction of tamoxifen-4-hydroxylation by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), beta-naphthoflavone (beta NF), and phenobarbital (PB) in avian liver: identification of P450 TCDDAA as catalyst of 4-hydroxylation induced by TCDD and beta NF.
Kupfer D; Mani C; Lee CA; Rifkind AB
Cancer Res; 1994 Jun; 54(12):3140-4. PubMed ID: 8205532
[TBL] [Abstract][Full Text] [Related]
6. [In vivo occupation of estrogen receptors by hydroxylated metabolites of tamoxifen].
Borgna JL; Rochefort H
C R Seances Acad Sci D; 1979 Dec; 289(15):1141-4. PubMed ID: 121266
[TBL] [Abstract][Full Text] [Related]
7. A comparative study of tamoxifen metabolism in female rat, mouse and human liver microsomes.
Lim CK; Yuan ZX; Lamb JH; White IN; De Matteis F; Smith LL
Carcinogenesis; 1994 Apr; 15(4):589-93. PubMed ID: 8149466
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationships of nonisomerizable derivatives of tamoxifen: importance of hydroxyl group and side chain positioning for biological activity.
Murphy CS; Parker CJ; McCague R; Jordan VC
Mol Pharmacol; 1991 Mar; 39(3):421-8. PubMed ID: 2005879
[TBL] [Abstract][Full Text] [Related]
9. Estrogenic stimulation of the antiestrogen specific binding site in rat uterus and liver.
Winneker RC; Clark JH
Endocrinology; 1983 Jun; 112(6):1910-5. PubMed ID: 6682755
[TBL] [Abstract][Full Text] [Related]
10. A monohydroxylated metabolite of tamoxifen with potent antioestrogenic activity.
Jordan VC; Collins MM; Rowsby L; Prestwich G
J Endocrinol; 1977 Nov; 75(2):305-16. PubMed ID: 591813
[TBL] [Abstract][Full Text] [Related]
11. Extensive in situ activation of nuclear estrogen receptors after exposure of murine uteri to [3H]estradiol or [3H]4-hydroxytamoxifen.
Pavlik EJ; Nelson K; van Nagell JR; Donaldson ES; Walden ML; Gallion H; Kenady DE
Endocrinology; 1987 Apr; 120(4):1608-14. PubMed ID: 3830064
[TBL] [Abstract][Full Text] [Related]
12. Opposing biological actions of antiestrogens in vitro and in vivo: induction of progesterone receptor in the rat and mouse uterus.
Campen CA; Jordan VC; Gorski J
Endocrinology; 1985 Jun; 116(6):2327-36. PubMed ID: 3996316
[TBL] [Abstract][Full Text] [Related]
13. The formation of estrogen-like tamoxifen metabolites and their influence on enzyme activity and gene expression of ADME genes.
Johänning J; Kröner P; Thomas M; Zanger UM; Nörenberg A; Eichelbaum M; Schwab M; Brauch H; Schroth W; Mürdter TE
Arch Toxicol; 2018 Mar; 92(3):1099-1112. PubMed ID: 29285606
[TBL] [Abstract][Full Text] [Related]
14. New evidence that the antiestrogen binding site may be a novel growth-promoting histamine receptor (?H3) which mediates the antiestrogenic and antiproliferative effects of tamoxifen.
Brandes LJ; Bogdanovic RP
Biochem Biophys Res Commun; 1986 Jan; 134(2):601-8. PubMed ID: 3947341
[TBL] [Abstract][Full Text] [Related]
15. The deuterium isotope effect for the alpha-hydroxylation of tamoxifen by rat liver microsomes accounts for the reduced genotoxicity of [D5-ethyl]tamoxifen.
Jarman M; Poon GK; Rowlands MG; Grimshaw RM; Horton MN; Potter GA; McCague R
Carcinogenesis; 1995 Apr; 16(4):683-8. PubMed ID: 7728943
[TBL] [Abstract][Full Text] [Related]
16. Metabolism of tamoxifen by isolated rat hepatocytes. Identification of 1-[4-(2-hydroxyethoxy)phenyl]-1-(4-hydroxyphenyl)-2-phenyl-1-butene and the dependence of N-oxidation on oxygen availability.
Parr IB; McCague R; Leclercq G; Stoessel S
Biochem Pharmacol; 1987 May; 36(9):1513-9. PubMed ID: 3579987
[TBL] [Abstract][Full Text] [Related]
17. Species differences in metabolism of panomifene, an analogue of tamoxifen.
Monostory K; Jemnitz K; Vereczkey L; Czira G
Drug Metab Dispos; 1997 Dec; 25(12):1370-8. PubMed ID: 9394026
[TBL] [Abstract][Full Text] [Related]
18. DNA adduct formation and mutant induction in Sprague-Dawley rats treated with tamoxifen and its derivatives.
Gamboa da Costa G; McDaniel-Hamilton LP; Heflich RH; Marques MM; Beland FA
Carcinogenesis; 2001 Aug; 22(8):1307-15. PubMed ID: 11470763
[TBL] [Abstract][Full Text] [Related]
19. Estrogen receptor-binding affinity of tamoxifen analogs with various side chains and their biologic profile in immature rat uterus.
Agarwal AK; Bindal RD
Steroids; 1991 Sep; 56(9):486-9. PubMed ID: 1805462
[TBL] [Abstract][Full Text] [Related]
20. Antagonism to estradiol in the mouse: reduced entry of receptors complexed with 4-hydroxytamoxifen into a Mg2+-soluble chromatin fraction.
Pavlik EJ; van Nagell JR; Nelson K; Gallion H; Donaldson ES; Kenady DE; Baranowska-Kortylewicz J
Endocrinology; 1986 May; 118(5):1924-34. PubMed ID: 2422013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
